Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions for the treatment of spinal disorders, today is pleased to announce the expansion of its executive leadership team by appointing Charles R. Gordon as the Executive Chairman of the Board. This strategic move is poised to enhance the company's innovative edge and entry into the minimally invasive interventional spine market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231207369019/en/
Dr. Charles Gordon has joined Wenzel Spine as Executive Chairman. In working with Wenzel Spine's new CEO, Dr. Charles Gordon helped identify new growth opportunities for Wenzel Spine technology in both new market segments and new technology adopters. (Photo: Business Wire, Inc.)
William Wilson, CEO of Wenzel Spine, commented on the recent expansion, saying, "The addition of Dr. Gordon to our executive team and our engagement with MM Dillon & Co. represent significant steps forward for Wenzel Spine. We are confident that these strategic moves will enhance our ability to deliver innovative and effective spine solutions addressing our entry into MI interventional spine for our clients, partners and their patients."
Dr. Gordon was the founding Chairman of the Board for Baylor Scott & White's Texas Spine & Joint Hospital. Over the years the hospital has grown, and majority interest of the hospital was sold to Baylor Scott & White and United Surgical Partners International (USPI). The real estate was also sold in a separate transaction to a large publicly traded real estate investment trust. Dr. Gordon holds over 80 distinct patents all in the life science area. He remains active in medical practice and is excited about the possibility of adding value to his partners and stakeholders, across-the-board. "I am thrilled to join the Wenzel Spine executive leadership team," said Dr. Gordon. "I believe my extensive experience and proven track record in the industry will be invaluable as we continue to grow and innovate in the field of spine care. I think Wenzel Spine has the capability to quickly enter the minimally invasive interventional spine market with unique technologies."
In addition to expanding its leadership team, Wenzel Spine has engaged with MM Dillon & Co., a boutique investment bank, to assist with strategic options, which may include raising capital for strategic growth. Michiel McCarty, Chairman & CEO of MM Dillon & Co., expressed his enthusiasm about the engagement, stating, "We are excited to work with Wenzel Spine, a company that is at the forefront of innovation in spine care. Our team is committed to assisting Wenzel Spine in exploring strategic options to further their growth and impact in the industry."
About MM Dillon & Co.
M.M. Dillon is a Leading Healthcare and Technology Focused Boutique Investment Bank that offers a unique blend of extraordinary senior transaction execution capabilities combined with extensive C-Suite corporate sector experience. Founded in 2004, headquartered in Greenwich Connecticut in the heart of many hedge fund investors, M.M. Dillon works with leading public and private healthcare and technology companies, hedge funds, private equity and venture capital firms across the healthcare and technology landscape with a primary focus on Biotech, Biopharma, Specialty Pharma, Devices, Software, Security and Equipment.
About Wenzel Spine, Inc.
Wenzel Spine, Inc. is a medical technology company focused on providing minimally invasive solutions and diagnostics for the treatment of spinal disorders. Headquartered in Austin, TX, Wenzel Spine is focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. Wenzel Spine seeks to improve patient quality of life by designing and producing devices of the highest quality to support our surgeon clients in the care and treatment of their patients. For more information visit: www.wenzelspine.com/